8725 related articles for article (PubMed ID: 23238532)
1. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
Hibberd AD; Trevillian PR; Wlodarczyk JH; Kemp DG; Stein AM; Gillies AH; Heer MK; Sheil AG
Transplantation; 2013 Jan; 95(1):122-7. PubMed ID: 23238532
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
Vajdic CM; van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; Chapman JR; Amin J; McDonald SP; Grulich AE
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2297-303. PubMed ID: 19622722
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression and other risk factors for lip cancer after kidney transplantation.
van Leeuwen MT; Grulich AE; McDonald SP; McCredie MR; Amin J; Stewart JH; Webster AC; Chapman JR; Vajdic CM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):561-9. PubMed ID: 19190169
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
5. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cancer in the renal transplant population: epidemiological study.
Pond F; Serpell JW; Webster A
ANZ J Surg; 2005 Mar; 75(3):106-9. PubMed ID: 15777384
[TBL] [Abstract][Full Text] [Related]
8. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain.
Marcén R; Morales JM; Arias M; Fernández-Juárez G; Fernández-Fresnedo G; Andrés A; Rodrigo E; Pascual J; Domínguez B; Ortuño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S286-90. PubMed ID: 17130276
[TBL] [Abstract][Full Text] [Related]
9. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
10. Excess risk of cancer in renal transplant patients.
Kessler M; Jay N; Molle R; Guillemin F
Transpl Int; 2006 Nov; 19(11):908-14. PubMed ID: 17018126
[TBL] [Abstract][Full Text] [Related]
11. Time on dialysis and cancer risk after kidney transplantation.
Wong G; Turner RM; Chapman JR; Howell M; Lim WH; Webster AC; Craig JC
Transplantation; 2013 Jan; 95(1):114-21. PubMed ID: 23222892
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004.
Guerra AA; Cesar CC; Cherchiglia ML; Andrade EI; de Queiroz OV; Silva GD; de Assis Acurcio F
Ann Pharmacother; 2010 Jan; 44(1):192-201. PubMed ID: 20009005
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
[TBL] [Abstract][Full Text] [Related]
14. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence before and after kidney transplantation.
Vajdic CM; McDonald SP; McCredie MR; van Leeuwen MT; Stewart JH; Law M; Chapman JR; Webster AC; Kaldor JM; Grulich AE
JAMA; 2006 Dec; 296(23):2823-31. PubMed ID: 17179459
[TBL] [Abstract][Full Text] [Related]
16. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.
van Leeuwen MT; Webster AC; McCredie MR; Stewart JH; McDonald SP; Amin J; Kaldor JM; Chapman JR; Vajdic CM; Grulich AE
BMJ; 2010 Feb; 340():c570. PubMed ID: 20150194
[TBL] [Abstract][Full Text] [Related]
17. No increase of melanoma after kidney transplantation in the northern part of The Netherlands.
Bastiaannet E; Homan-van der Heide JJ; Ploeg RJ; Hoekstra HJ
Melanoma Res; 2007 Dec; 17(6):349-53. PubMed ID: 17992116
[TBL] [Abstract][Full Text] [Related]
18. Depressive disorder in renal transplantation: an analysis of Medicare claims.
Dobbels F; Skeans MA; Snyder JJ; Tuomari AV; Maclean JR; Kasiske BL
Am J Kidney Dis; 2008 May; 51(5):819-28. PubMed ID: 18436093
[TBL] [Abstract][Full Text] [Related]
19. A long-term study on hyperlipidemia in stable renal transplant recipients.
Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
[TBL] [Abstract][Full Text] [Related]
20. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
